Gene Editing And Genomics companies

Mass General Brigham Ventures is an early-stage venture capital firm founded in 2008 to advance new life science technologies emerging from Mass General Brigham…

4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector.

We invest in relentlessly ambitious entrepreneurs.

Investing at the convergence of biology and computing to support a new generation of breakthrough technologies.

We fund healthy lifespan extension.

Investing in pre-seed and seed stage biotech start-ups within a niche focus in bio-remediation, bioengineering, cell & gene therapy, and longevity.

Since 2004, Amgen Ventures has invested in emerging companies to help discover promising medicines and technologies that will bring "Value Healthcare" to patien…